Dr Richard Scolyer, a distinguished pathologist and melanoma specialist renowned for his innovative research, has passed away at the age of 59 after a brave battle with grade-four inoperable brain cancer. His family announced the news, sharing a heartfelt letter from Scolyer that reflects his gratitude for the support he received throughout his illness.
A Legacy of Hope and Innovation
Scolyer, who was diagnosed with a terminal brain tumour in May 2023, had a profound impact on cancer research, particularly in the field of immunotherapy. His groundbreaking work not only advanced medical understanding of melanoma but also offered hope to countless patients. In a bold and unprecedented move, Scolyer chose to undergo experimental immunotherapy treatments on himself, managing to slow the progression of his disease until its recurrence in early 2025.
In his poignant farewell message, he expressed deep appreciation for the love and encouragement he received from the Australian public, his colleagues, and his online community. “You’ve laughed with me, cried with me, and provided encouragement and support to keep going just when I needed it most,” he wrote. He hoped his journey would inspire others to pursue their dreams with humility and compassion.
A National Figure in Cancer Research
Scolyer’s contributions to cancer research were significant, earning him accolades that included being jointly named Australian of the Year in 2024 alongside his colleague, Dr Georgina Long. The duo was recognised for their pioneering work in developing immunotherapy as a viable treatment for advanced melanoma. Over his illustrious career, Scolyer received the New South Wales Premier’s Award for Outstanding Cancer Research on nine occasions, cementing his status as a leader in the field.
Prime Minister Anthony Albanese paid tribute to Scolyer, describing him as “one of our brightest lights and one of our biggest hearts.” He confirmed that a state funeral would be held in honour of the esteemed researcher, highlighting Scolyer’s courage and willingness to share his personal battle with cancer publicly. “Richard’s journey was difficult and confronting… yet it was one he travelled with courage, determination, and grace,” Albanese noted.
Community Support and Personal Resilience
Throughout his illness, Scolyer maintained a connection with the community, often sharing updates on his condition with his large following on social media. In March, he candidly revealed that his cancer had advanced, stating, “Not the best day ever… it’s not the end of the road and I’ve got more to do!” His optimism and resilience resonated with many, showcasing the power of hope in the face of adversity.
Friends, colleagues, and patients have shared their condolences and stories, reflecting on how Scolyer’s work has transformed lives. Professor John Thompson from Sydney University praised his “cheery, down-to-earth ‘lad from Launceston’ personality” and noted the immense benefits his research has brought to cancer patients worldwide.
Why it Matters
Dr Richard Scolyer’s passing marks a significant loss not only for the field of cancer research but also for the broader community that he inspired through his courage and dedication. His legacy will undoubtedly live on in the lives of those he touched, as well as in the advancements he made in melanoma treatment. Scolyer’s journey highlights the importance of hope, resilience, and the human spirit in the face of life-threatening challenges, serving as a reminder of the profound impact one individual can have on the world.